- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/22 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups in which the condensed systems contains four or more hetero rings
Patent holdings for IPC class C07D 471/22
Total number of patents in this class: 869
10-year publication summary
|
54
|
35
|
57
|
55
|
59
|
61
|
70
|
82
|
69
|
55
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5742 |
31 |
| King Faisal University | 936 |
30 |
| Gilead Sciences, Inc. | 2243 |
23 |
| Intra-Cellular Therapies, Inc. | 438 |
15 |
| Merck Sharp & Dohme LLC | 3734 |
15 |
| Boehringer Ingelheim International GmbH | 4488 |
14 |
| Sumitomo Chemical Company, Limited | 8967 |
13 |
| Arizona Board of Regents on behalf of Arizona State University | 2975 |
13 |
| Shionogi & Co., Ltd. | 885 |
13 |
| Samsung Display Co., Ltd. | 39012 |
12 |
| Incyte Corporation | 1070 |
12 |
| Demerx, Inc. | 76 |
11 |
| Array BioPharma Inc. | 438 |
10 |
| FUJIFILM Corporation | 30653 |
9 |
| The University of Tokyo | 4386 |
9 |
| Janssen Pharmaceutica N.V. | 3150 |
8 |
| Capacitor Sciences Incorporated | 56 |
8 |
| Incyte Holdings Corporation | 626 |
8 |
| Genfleet Therapeutics (Shanghai) Inc. | 70 |
8 |
| Novartis AG | 10174 |
7 |
| Other owners | 600 |